Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist

Arch Dermatol. 2009 Dec;145(12):1363-6. doi: 10.1001/archdermatol.2009.283.

Abstract

Primary cicatricial alopecias (PCAs), rare disorders that lead to permanent hair loss, have been poorly understood and are difficult to treat. Lichen planopilaris (LPP)is a prototypical PCA; patients often present with sudden onset of hair loss and clinically significant symptoms of itching, burning, and pain of the scalp. Examination reveals patchy alopecia or a more diffuse thinning of the scalp with characteristic perifollicular erythema and perifollicular scale at the margins of the areas of alopecia.Treatment typically includes use of antiinflammatory medications; although symptoms may improve,hair loss is often progressive.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alopecia / drug therapy
  • Alopecia / etiology
  • Alopecia / pathology
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Lichen Planus / drug therapy*
  • Lichen Planus / pathology*
  • Male
  • Middle Aged
  • PPAR gamma / agonists*
  • Pioglitazone
  • Scalp Dermatoses / drug therapy*
  • Scalp Dermatoses / pathology
  • Thiazolidinediones / therapeutic use*

Substances

  • Hypoglycemic Agents
  • PPAR gamma
  • Thiazolidinediones
  • Pioglitazone